{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:00:13Z","timestamp":1784034013681,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.hpb.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T10:31:39Z","timestamp":1553509899000},"page":"1427-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Carlos","family":"Manterola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galo","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"de Aretxabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque","family":"Conejeros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Otzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayely","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.02.019_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.gtc.2010.02.011","article-title":"Epidemiology of gallbladder cancer","volume":"39","author":"Eslick","year":"2010","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.hpb.2019.02.019_bib2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins","volume":"16","author":"Glazer","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib3","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2019.02.019_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21037\/cco.2016.08.05","article-title":"Adjuvant therapy for resected biliary tract cancer: a review","volume":"5","author":"Doherty","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jso.20538","article-title":"Chemoradiotherapy in gallbladder cancer","volume":"93","author":"de Aretxabala","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11605-007-0115-1","article-title":"Surgical management of gallbladder carcinoma: a review","volume":"11","author":"Mekeel","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-018-0664-3","article-title":"Updates on gallbladder cancer management","volume":"20","author":"Zaidi","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hpb.2019.02.019_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.02.019_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.02.019_bib11","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant therapy for gallbladder cancer: an analysis of the national cancer data Base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib12","series-title":"SIGN 50: a guidelines developers' handbook","author":"Scottish Intercollegiate Guidelines Network","year":"2004"},{"key":"10.1016\/j.hpb.2019.02.019_bib13","series-title":"OCEBM levels of evidence","author":"Centre for Evidence-Based Medicine","year":"2009"},{"key":"10.1016\/j.hpb.2019.02.019_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hpb.2019.02.019_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","article-title":"Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis","volume":"25","author":"Kim","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.30968","article-title":"The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts","volume":"124","author":"Tran Cao","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.02.019_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0019-509X.118723","article-title":"Adjuvant chemoradiation for resected gallbladder cancer: treatment strategies for one of the leading causes of cancer death in Chilean women","volume":"50","author":"M\u00fcller","year":"2013","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.hpb.2019.02.019_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4143\/crt.2015.502","article-title":"Is there a role for adjuvant therapy in RO resected gallbladder cancer?: a propensity score-matched analysis","volume":"48","author":"Go","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.hpb.2019.02.019_bib20","article-title":"Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data Base","volume":"109","author":"Mantripragada","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2019.02.019_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2019.02.019_bib22","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2147\/OTT.S166246","article-title":"Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection","volume":"11","author":"Chen","year":"2018","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.hpb.2019.02.019_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000002385","article-title":"Surgical management of gallbladder cancer simple versus extended cholecystectomy and the role of adjuvant therapy","volume":"266","author":"Kasumova","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3857\/roj.2017.00388","article-title":"Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy","volume":"35","author":"Kim","year":"2017","journal-title":"Rad Oncol J"},{"key":"10.1016\/j.hpb.2019.02.019_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdw199.210","article-title":"Survival in incidental gallbladder cancer treated with short-course radiotherapy after simple cholecystectomy without re-exploration, and evaluation of tumor biomarkers: the experience at the National Cancer Institute (Mexico)","volume":"27","author":"Zamora-Moreno","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12029-014-9676-x","article-title":"Outcomes of adjuvant chemoradiation and predictors of survival after extended cholecystectomy in gall bladder carcinoma: a single Institution experience from an endemic region","volume":"246","author":"Agrawal","year":"2015","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2019.02.019_bib27","first-page":"XC01","article-title":"Impact of adjuvant therapy on survival in curatively resected gallbladder carcinoma","volume":"9","author":"Choudhary","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.hpb.2019.02.019_bib28","first-page":"5621","article-title":"Postoperative radiotherapy for gallbladder cancer","volume":"34","author":"Jeong","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hpb.2019.02.019_bib29","first-page":"3125","article-title":"Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer","volume":"34","author":"Nakamura","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hpb.2019.02.019_bib30","first-page":"207","article-title":"Potential for adjuvant treatment after radical resection in carcinoma gallbladder: a tertiary care experience from India","volume":"2","author":"Kapoor","year":"2013","journal-title":"Clin Cancer Invest J"},{"key":"10.1016\/j.hpb.2019.02.019_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/jco.2013.31.4_suppl.289","article-title":"Postoperative radiotherapy for gallbladder cancer","volume":"31","author":"Park","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib32","first-page":"534","article-title":"Analysis of the efficacy of postoperative radiotherapy in gallbladder cancer","volume":"35","author":"Yang","year":"2013","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"10.1016\/j.hpb.2019.02.019_bib33","first-page":"634","article-title":"The survival analysis of 54 patients with locally advanced gallbladder cancer receiving postoperative adjuvant chemoradiotherapy","volume":"33","author":"Ye","year":"2013","journal-title":"Tumor"},{"key":"10.1016\/j.hpb.2019.02.019_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00066-012-0074-7","article-title":"Postoperative chemoradiotherapy for gallbladder cancer","volume":"188","author":"Kim","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hpb.2019.02.019_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12094-011-0685-y","article-title":"Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer","volume":"13","author":"Gonz\u00e1lez","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3748\/wjg.v17.i3.397","article-title":"Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy","volume":"17","author":"Sun","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2019.02.019_bib37","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2004.12.059","article-title":"Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience","volume":"62","author":"Czito","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hpb.2019.02.019_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000322914","article-title":"Outcome of adjuvant therapy for gallbladder c\u00e1ncer","volume":"79","author":"Park","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.hpb.2019.02.019_bib39","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1245\/s10434-016-5262-8","article-title":"Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jso.21544","article-title":"Adjuvant chemoradiation therapy in gallbladder cancer","volume":"102","author":"Cho","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma","volume":"14","author":"Kim","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.02.019_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","article-title":"Adjuvant therapy for gallbladder carcinoma: the Mayo clinic experience","volume":"75","author":"Gold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hpb.2019.02.019_bib43","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-005-3040-8","article-title":"Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder","volume":"50","author":"Itoh","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hpb.2019.02.019_bib44","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(01)01764-3","article-title":"Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma","volume":"52","author":"Kresl","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hpb.2019.02.019_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.20831","article-title":"Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease","volume":"96","author":"Mojica","year":"2007","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.02.019_bib47","first-page":"580","article-title":"Intraoperative radiation therapy for gallbladder cancer: experience at a single Institution","volume":"61","author":"Lee","year":"2014","journal-title":"Hepato-gastroenterology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19301042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19301042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:19:33Z","timestamp":1761265173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19301042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1365182X19301042"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.02.019","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}